Health Insurance Review and Assessment Service

Class- and dose-dependent heterogeneity in the risk of medication-related osteonecrosis of the jaw among antiresorptive agents: a nationwide new-user cohort study using Korean National Health Insurance claims data

Antiresorptive agents are widely used to treat osteoporosis and skeletal complications of malignancy, but long-term use can lead to medication-related osteonecrosis of the jaw (MRONJ). No nationwide Korean study has directly compared oral and intravenous bisphosphonates with low-...